Stratec Biomedical AG | Ownership
Companies that own Stratec Biomedical AG
OppenheimerFunds, Inc.
751,899
6.29%
0
0.04%
02/28/2018
Threadneedle Asset Management Ltd.
732,073
6.12%
22,612
0.09%
07/31/2018
Allianz Global Investors GmbH (France)
600,000
5.01%
0
0.09%
12/31/2015
BNP Paribas Asset Management Belgium SA
211,432
1.77%
0
0.15%
07/31/2018
Comgest SA
192,611
1.61%
9,780
0.07%
05/31/2018
Lupus alpha Asset Management AG
163,800
1.37%
-45,174
0.73%
12/31/2017
Mawer Investment Management Ltd.
156,000
1.3%
156,000
0.05%
12/31/2017
Amundi Asset Management SA (Investment Management)
154,952
1.3%
0
0.02%
01/31/2018
Credit Suisse Asset Management (Schweiz) AG
116,538
0.97%
25,000
0.01%
07/31/2018
Schroder Investment Management Ltd.
112,609
0.94%
2,778
0.01%
06/30/2018
| Address |
Gewerbestrasse 37
Birkenfeld Rheinland-Pfalz 75217
Germany
|
|
Employees
|
- |
| Website |
http://www.stratec.com |
| Updated |
07/08/2019 |
| STRATEC Biomedical AG engages in the design and manufacture of automated analyzer systems in the field of clinical diagnostic and biotechnology. It operates through the following segments: Instrumentation, Diatron, Consumables, and Other Activities. The Instrumentation segment refers to the design and manufacture of fully automated analyzer systems for its clinical diagnostic and biotechnology customers. |
